Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report

Blood Adv. 2022 May 24;6(10):3162-3166. doi: 10.1182/bloodadvances.2021006383.

Ko Kudo¹, Yasuo Kubota², Tsutomu Toki¹, Rika Kanezaki¹, Akie Kobayashi¹, Tomohiko Sato¹, Takuya Kamio¹, Shinya Sasaki¹, Norio Shiba³, Daisuke Tomizawa⁴, Souichi Adachi⁵, Kenichi Yoshida⁶, Seishi Ogawa^{6

7

8}, Masafumi Seki², Junko Takita^{2

3

4

5

6

7

8

9}, Etsuro Ito¹, Kiminori Terui¹

¹ Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
² Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Bunkyo City, Tokyo, Japan.
³ Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
⁴ National Center for Child Health and Development Children's Cancer Center, Tokyo, Japan.
⁵ Department of Human Health Sciences.
⁶ Department of Pathology and Tumor Biology, Graduate School of Medicine, and.
⁷ Institute for the Advanced Study of Human Biology (WPI ASHBi), Kyoto University, Kyoto, Japan.
⁸ Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden; and.
⁹ Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

No abstract available

Publication types